1. Home
  2. NBTX vs ASA Comparison

NBTX vs ASA Comparison

Compare NBTX & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • ASA
  • Stock Information
  • Founded
  • NBTX 2003
  • ASA 1958
  • Country
  • NBTX France
  • ASA United States
  • Employees
  • NBTX N/A
  • ASA N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • ASA Precious Metals
  • Sector
  • NBTX Health Care
  • ASA Industrials
  • Exchange
  • NBTX Nasdaq
  • ASA Nasdaq
  • Market Cap
  • NBTX 868.8M
  • ASA 697.1M
  • IPO Year
  • NBTX 2020
  • ASA N/A
  • Fundamental
  • Price
  • NBTX $27.75
  • ASA $51.35
  • Analyst Decision
  • NBTX Strong Buy
  • ASA
  • Analyst Count
  • NBTX 1
  • ASA 0
  • Target Price
  • NBTX $8.00
  • ASA N/A
  • AVG Volume (30 Days)
  • NBTX 162.1K
  • ASA 149.4K
  • Earning Date
  • NBTX 09-30-2025
  • ASA 10-28-2025
  • Dividend Yield
  • NBTX N/A
  • ASA 0.12%
  • EPS Growth
  • NBTX N/A
  • ASA 335.96
  • EPS
  • NBTX N/A
  • ASA 19.90
  • Revenue
  • NBTX $11,930,711.00
  • ASA $3,982,215.00
  • Revenue This Year
  • NBTX N/A
  • ASA N/A
  • Revenue Next Year
  • NBTX $114.97
  • ASA N/A
  • P/E Ratio
  • NBTX N/A
  • ASA $2.46
  • Revenue Growth
  • NBTX N/A
  • ASA 99.75
  • 52 Week Low
  • NBTX $2.76
  • ASA $19.37
  • 52 Week High
  • NBTX $30.35
  • ASA $50.75
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 66.10
  • ASA 76.76
  • Support Level
  • NBTX $23.31
  • ASA $46.18
  • Resistance Level
  • NBTX $29.72
  • ASA $49.14
  • Average True Range (ATR)
  • NBTX 2.12
  • ASA 1.76
  • MACD
  • NBTX 0.66
  • ASA 0.15
  • Stochastic Oscillator
  • NBTX 80.80
  • ASA 85.93

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: